Welcome to our dedicated page for Halliburton SEC filings (Ticker: HAL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Halliburton Company (HAL) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Halliburton, one of the world’s leading providers of products and services to the energy industry, uses these filings to report financial results, material agreements, leadership changes, and other significant events. This page organizes those documents and pairs them with AI-powered summaries to help readers understand their key points.
Investors can review current reports on Form 8-K, where Halliburton discloses items such as quarterly earnings releases, executive and board appointments, new executive agreements, and material credit facilities. For example, recent 8-K filings describe the appointment of senior leaders including an Executive Vice President and Chief Operating Officer, presidents for the Eastern and Western Hemispheres, a new chief accounting officer, and the addition of a board member. Other 8-Ks outline a multi-billion-dollar revolving credit agreement and the termination of a prior facility, as well as Halliburton’s minority interest in Voltagrid.
Filings related to results of operations and financial condition furnish earnings press releases that detail segment and regional performance, non-GAAP measures with reconciliations, and commentary on business conditions in Completion and Production and Drilling and Evaluation. These documents complement the company’s earnings calls and provide a structured view of Halliburton’s financial reporting.
Users interested in governance and compensation can find information on executive agreements and indemnification arrangements referenced in 8-K exhibits and proxy materials, which describe base salaries, participation in incentive plans, and indemnification terms for directors and executive officers. This page is updated as new filings are posted to EDGAR, while AI-generated highlights help readers quickly identify the sections most relevant to topics such as quarterly performance, capital structure, leadership changes, and significant contracts.
Halliburton Company executive Stephanie Spoelker Holzhauser, SVP & Chief Accounting Officer, transferred 4,336 shares of common stock to Halliburton on January 8, 2026 to cover federal tax withholding on vested stock awards. The shares were valued at $29.60 per share, based on the January 2, 2026 New York Stock Exchange closing price, as allowed under the company’s Stock and Incentive Plan. After this withholding-related transfer, she beneficially owned 68,974.422 shares of Halliburton common stock directly.
She also continued to hold stock options directly, including options exercisable for 9,688 shares of common stock at an exercise price of $49.61 per share expiring January 2, 2028, and options for 7,994 shares at $55.68 per share expiring January 3, 2027. The filing characterizes the reported share movement as satisfying tax obligations tied to previously granted restricted stock that vested in early January 2026.
Halliburton Company’s EVP & Chief Financial Officer Eric Carre reported a routine share withholding related to equity compensation. On January 8, 2026, 6,283 shares of common stock were transferred to Halliburton to cover federal tax withholding triggered by the lapse of restrictions on previously granted stock under the company’s Stock and Incentive Plan, at a reference price of $29.60 per share.
After this tax-related transaction, Carre beneficially owned 153,436.623 shares of Halliburton common stock directly. He also held vested stock options directly, including 50,100 options with a $31.44 exercise price expiring December 5, 2028, 34,425 options at $43.38 expiring December 6, 2027, and 30,100 options at $53.54 expiring December 7, 2026.
A shareholder in HAL filed a Rule 144 notice to sell 23,895 common shares through Fidelity Brokerage Services on the NYSE, with an indicated aggregate market value of
The shares come from recently vested restricted stock awards from the issuer, including 10,639 shares acquired on
Shareholder Van Beckwith has filed a notice of proposed sale under Rule 144 to sell 17,798 shares of common stock through Fidelity Brokerage Services LLC on or around 01/09/2026, on the NYSE, with an indicated aggregate market value of $574,875.40. These shares come from restricted stock that vested on 01/02/2026 and 01/03/2026, in blocks of 8,973 and 8,825 shares respectively, both described as compensation. The notice also reports that over the prior three months, the same shareholder sold 8,854 common shares for gross proceeds of $246,938.06. The filing includes a representation that the seller is not aware of undisclosed material adverse information about the issuer’s operations.
Halliburton Company officer updates insider holdings in amended report. The President - Eastern Hemisphere of Halliburton, filing individually, corrected his direct beneficial ownership after an administrative error was identified.
Following the correction, he directly holds 147,163.837 shares of Halliburton common stock. He also holds several stock options: an option to buy 11,775 shares at $24.68 per share exercisable until 01/02/2030, an option to buy 9,517 shares at $27.30 per share until 01/02/2029, an option to buy 4,323 shares at $49.61 per share until 01/02/2028, and an option to buy 7,829 shares at $43.84 per share until 08/14/2026. The issuer is Halliburton Co (HAL), and the earliest transaction date reported is 01/02/2026.
Halliburton Company updated the reported holdings of its President - Eastern Hemisphere, Mr. Yassine, due to an earlier administrative error. The corrected filing shows he directly beneficially owns 106,007.837 shares of common stock as of January 1, 2026.
He also holds several stock options to buy Halliburton common stock, including 11,775 shares at $24.68 expiring January 2, 2030, 9,517 shares at $27.30 expiring January 2, 2029, 4,323 shares at $49.61 expiring January 2, 2028, and 7,829 shares at $43.84 expiring August 14, 2026. The change reflects a correction to his initial statement filed January 2, 2026, which had understated his direct beneficial ownership.
Halliburton Company executive reports stock award and planned share sale
A Halliburton Company executive serving as EVP and Chief Administrative Officer reported equity transactions in Halliburton common stock. On January 2, 2026, the reporting person acquired 34,968 shares of common stock pursuant to the Halliburton Company Stock and Incentive Plan, which allows surrender of shares to satisfy tax withholding. The closing price of Halliburton common stock on the New York Stock Exchange on that grant date was $29.60 per share.
On January 5, 2026, the executive sold 100,000 shares of common stock at a price of $32.25 per share pursuant to a Rule 10b5-1 trading plan adopted on August 8, 2025. Following these transactions, the executive directly beneficially owned 419,799.685 shares of Halliburton common stock and held vested stock options covering additional shares with exercise prices between $31.44 and $53.54.
Halliburton Company reported an insider equity award for a senior executive. On January 2, 2026, a director and Executive Vice President & Chief Operating Officer received 56,178 shares of common stock under the Halliburton Company Stock and Incentive Plan. The plan allows shares to be surrendered to Halliburton to cover tax withholding obligations. The closing price of Halliburton common stock on the New York Stock Exchange on the grant date was $29.60 per share. After this grant, the insider directly beneficially owned 219,229.952 shares of common stock. The filing also shows stock options with exercise prices of $55.68 (3,722 shares, expiring January 3, 2027) and $49.61 (12,090 shares, expiring January 2, 2028), while an older option expiring January 4, 2026 is now at zero.
Halliburton Company executive equity update: A Halliburton Co (HAL) officer, listed as President - Western Hemisphere, reported receiving 41,156 shares of common stock on 01/02/2026 under the Halliburton Company Stock and Incentive Plan. The grant is valued using the New York Stock Exchange closing price of $29.60 on the grant date. After this award, the reporting person beneficially owns 488,160.517 Halliburton shares, which includes 2,013.910 shares accumulated through dividend reinvestment as of December 31, 2025. The filing also notes a stock option for 28,604 shares at an exercise price of $34.48 that expired on January 4, 2026, while other options remain outstanding with exercise prices between $27.14 and $55.68 and expirations in 2027 and 2028.
Halliburton Company reported that its Senior Vice President and Treasurer acquired additional common stock through an equity award. On January 2, 2026, the officer was granted 5,610 shares of common stock under the Halliburton Company Stock and Incentive Plan, which allows shares to be surrendered to cover withholding taxes. The grant used the New York Stock Exchange closing price of $29.60 per share on the grant date. Following this award, the officer directly owned 82,736 shares of Halliburton common stock. The filing also lists existing stock options to buy Halliburton common shares at exercise prices of $31.44, $43.38, and $53.54, with expiration dates ranging from December 2026 to December 2028.
FAQ
What is the current stock price of Halliburton (HAL)?
What is the market cap of Halliburton (HAL)?
